EP3487506A1
|
|
Combinations of inecalcitol with an anti-cd38 agent and their uses for treating cancer
|
EP2565186A1
|
|
Selective and reversible inhibitors of ubiquitin specific protease 7
|
AU2011278346A1
|
|
New formulations of 14 - epi -analogues of vitamin D
|
UA110211C2
|
|
New storage 14-ei-vitamin d analogues
|
EP2357176A1
|
|
Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
|
EP2407152A1
|
|
Formulations of 14-epi-analogues of vitamin D
|
AU2010261967A1
|
|
New therapeutical uses of inecalcitol
|
EP2360145A1
|
|
New process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same
|
EP2208725A1
|
|
Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
|
AU2007315885A1
|
|
Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
|
EP1808493A2
|
|
Substrates and methods for assaying deubiquitinating enzymes activity
|
MX2008007195A
|
|
Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications.
|
EP1918292A1
|
|
Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
|
US2008103149A1
|
|
Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
|
AU2006277678A1
|
|
Novel cysteine protease inhibitors and their therapeutic applications
|
EP1798232A1
|
|
Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
|
US2007135439A1
|
|
Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
|
EP1749822A1
|
|
Novel cysteine protease inhibitors and their therapeutic applications
|
AU2003225506A1
|
|
Method for organizing and querying genomic and proteomic databases
|
AU2002365517A1
|
|
Protein-protein interactions involving transforming growth factor beta signalling
|